Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-15 · accession 0001055726-24-000028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-16 | 2024-05-15 | INO | Weiner David B. | Dir | M - OptEx | — | +2,166 | 82.5K | +3% | — |
| D | 2024-05-16 | 2024-05-15 | INO | Weiner David B. | Dir | M - OptEx | $0.00 | -2,166 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | M | A | 2,166 | — | 82,509 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 15, 2024. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. |
| 2 | Derivative | Restricted Stock Unit | 2024-05-15 | M | D | 2,166 | $0.00 | 0 | D | — · — to — | 2,166 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 15, 2024. |